Novo Nordisk Sues Sanofi-Aventis Over Insulin Delivery Patents
Danish drug maker Novo Nordisk A/S has sued its French rival Sanofi-Aventis over patents for its device for administering insulin to people living with diabetes....To view the full article, register now.
Already a subscriber? Click here to view full article